RESUMEN
Sudden sensorineural hearing loss following non-otologic surgery, under general anesthesia, is an extremely rare complication. Furthermore, postoperative deafness has more commonly been associated with cardiac surgery. This acute dysfunction of the inner ear consists a controversial subject in terms of etiopathogenic mechanisms and treatment modalities. We present the case of a 60-year-old male patient who underwent varicose vein surgery under general anesthesia and presented immediately after the operation bilateral and profound impairment of his hearing acuity. A high index of suspicion is required to early diagnosis of this complication, although prompt treatment does not guarantee a good outcome.
Asunto(s)
Anestesia por Inhalación , Pérdida Auditiva Bilateral/etiología , Pérdida Auditiva Sensorineural/etiología , Pérdida Auditiva Súbita/etiología , Complicaciones Posoperatorias/etiología , Várices/cirugía , Anestésicos por Inhalación/efectos adversos , Dióxido de Carbono/uso terapéutico , Diagnóstico Tardío , Diabetes Mellitus Tipo 2/complicaciones , Angiopatías Diabéticas/complicaciones , Diuréticos/efectos adversos , Diuréticos/uso terapéutico , Quimioterapia Combinada , Pérdida Auditiva Bilateral/tratamiento farmacológico , Pérdida Auditiva Sensorineural/tratamiento farmacológico , Pérdida Auditiva Súbita/tratamiento farmacológico , Humanos , Hipertensión/complicaciones , Hipertensión/tratamiento farmacológico , Masculino , Éteres Metílicos , Persona de Mediana Edad , Óxido Nitroso/efectos adversos , Oxígeno/uso terapéutico , Pentoxifilina/uso terapéutico , Complicaciones Posoperatorias/tratamiento farmacológico , Prednisolona/uso terapéutico , Sevoflurano , Acúfeno/etiologíaRESUMEN
PURPOSE: The purpose of this experimental study is to investigate the effects of iloprost on colonic anastomotic healing in rats, after intraperitoneal administration. METHODS: Forty male Albino-Wistar rats were randomized into two groups of twenty animals each. They all underwent colonic resection followed by an inverted anastomosis. The rats of Group A (control) received 3 ml of NaCl intraperitoneally, while those of Group B (iloprost) received iloprost (2 µg/kg body weight), immediately postoperatively and daily until killed. Each group was further divided into two equal subgroups, depending on the day of killing. The animals of subgroups 1 were killed on the fourth postoperative day, while those of subgroups 2 on the eighth. Macroscopical and histological assessments were performed. Besides, anastomotic bursting pressures and the tissue concentrations in hydroxyproline and collagenase I were also evaluated. RESULTS: No anastomotic dehiscence was noted. The mean bursting pressure was higher in the iloprost group compared with the control group, but a significant difference was revealed only on the fourth postoperative day. Furthermore, iloprost significantly increased the new vessel formation on the fourth, as well as on the eighth postoperative day. CONCLUSION: Iloprost enhances the early phase of colonic anastomotic healing in rats.
Asunto(s)
Colon/cirugía , Iloprost/farmacología , Vasodilatadores/farmacología , Cicatrización de Heridas/efectos de los fármacos , Anastomosis Quirúrgica , Animales , Colagenasas/análisis , Colagenasas/efectos de los fármacos , Colon/irrigación sanguínea , Colon/química , Colon/patología , Hidroxiprolina/análisis , Hidroxiprolina/efectos de los fármacos , Iloprost/efectos adversos , Masculino , Neovascularización Fisiológica/efectos de los fármacos , Presión/efectos adversos , Ratas , Ratas Wistar , Rotura/etiología , Factores de Tiempo , Adherencias Tisulares/etiología , Vasodilatadores/efectos adversosRESUMEN
Thyroid hormone (TH) signaling is altered in response to various stresses including myocardial ischemia. The present study investigated potential implication of TH signaling in the pathophysiology of postischemic remodeling. Acute myocardial infarction was induced in rats by coronary artery ligation (AMI). After 34 weeks, 6 animals were on congestive heart failure (CHF) as indicated by measurements in lung and right ventricular weight. 7 animals were in compensated state (Non-CHF) and 8 sham-operated animals (SHAM) served as controls. Progression to congestive heart failure was characterized by marked decrease in EF% and all other functional echocardiographic parameters. Furthermore, beta-MHC expression was significantly increased in CHF. A distinct pattern of thyroid hormone receptor (TR) expression was observed in the course of postischemic remodeling; TR alpha 1 was upregulated and TR beta 1 was downregulated in Non-CHF, and TR alpha 1 expression was markedly decreased during the transition from Non-CHF to CHF resulting in tissue hypothyroidism. Circulating T3 and T4 remained unchanged. This response was associated with marked decrease in mTOR activation. A potential link between mTOR and TR alpha 1 expression was shown in a neonatal cardiomyocytes model of PE (phenylephrine)-induced pathological growth. Phenylephrine increased the expression of TR alpha 1 in nucleus and this response was abrogated in the case of mTOR inhibition by rapamycin. In conclusion, progression to congestive heart failure after myocardial infarction is associated with suppressed expression of TR alpha 1 and results in tissue hypothyroidism. This process may, at least in part, be mTOR dependent.
Asunto(s)
Progresión de la Enfermedad , Regulación hacia Abajo , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/patología , Hipotiroidismo/complicaciones , Isquemia Miocárdica/complicaciones , Receptores alfa de Hormona Tiroidea/metabolismo , Animales , Animales Recién Nacidos , Regulación hacia Abajo/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Insuficiencia Cardíaca/sangre , Insuficiencia Cardíaca/diagnóstico por imagen , Hipotiroidismo/sangre , Masculino , Infarto del Miocardio/sangre , Infarto del Miocardio/complicaciones , Isquemia Miocárdica/sangre , Isquemia Miocárdica/diagnóstico por imagen , Miocardio/enzimología , Miocardio/patología , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/enzimología , Miosinas/metabolismo , Fenilefrina/farmacología , Isoformas de Proteínas/metabolismo , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Serina-Treonina Quinasas TOR/metabolismo , Hormonas Tiroideas/sangre , UltrasonografíaRESUMEN
Thyroid hormone (TH) is critical in cardiac cell differentiation (regulating contractile proteins and cell geometry) and this effect could be potentially exploited therapeutically in reversing the process of de-differentiation which underlies postischemic cardiac remodeling. Acute myocardial infarction was induced in male Wistar rats by ligating left coronary artery (AMI, n=8), while sham operated animals served as control (SHAM, n=8). 13 weeks after AMI, TH was administered in a group of animals for 4 weeks (AMI-THYR, n=9). TH significantly increased beta-MHC and decreased alpha-MHC expression in the myocardium. This response was accompanied by changes in cardiac geometry: sphericity index, (SI, long to short axis ratio) was found to be 1.95 (SEM, 0.02) in SHAM, 1.51(0.03) in AMI and 1.64(0.03) in AMI-THYR, p<0.05. As a consequence, cardiac function was significantly improved: left ventricular ejection fraction (EF%) was 74.5% (SEM, 2.8) in SHAM vs 29.5% (2.1) in AMI, and 40.0% in AMI-THYR, p<0.05. Furthermore, +dp/dt and -dp/dt were 4250 (127) and 2278 (55) in SHAM vs 2737(233) and 1508 (95) in AMI vs 3866 (310) and 2137(111) in AMI -THYR, respectively, p<0.05. TH treatment partially reverses cardiac dysfunction in rats with old myocardial infarction by favorably changing cardiac chamber geometry and expression of myosin isoforms. Thyroid hormone, unlike current treatments, appears to be a paradigm of therapeutic intervention which aims at restoring cardiac geometry and may prove new effective treatment for heart failure.
Asunto(s)
Infarto del Miocardio/tratamiento farmacológico , Miocardio/patología , Hormonas Tiroideas/fisiología , Hormonas Tiroideas/uso terapéutico , Remodelación Ventricular/efectos de los fármacos , Animales , Ecocardiografía , Insuficiencia Cardíaca/prevención & control , Masculino , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/fisiopatología , Miocardio/metabolismo , Cadenas Pesadas de Miosina/metabolismo , Isoformas de Proteínas , Ratas , Ratas Wistar , Hormonas Tiroideas/administración & dosificación , Hormonas Tiroideas/farmacocinética , Factores de TiempoRESUMEN
OBJECTIVES: The aims of this study were to investigate a possible positive correlation between B2-microglobulin (B2-M) serum levels and the severity and activity of inflammatory bowel disease (IBD); and to examine whether B2-M levels reflect IBD extent. METHODS: We examined B2-M serum levels in 87 ulcerative colitis (UC) patients, 74 with Crohn's disease (CD) and 68 control subjects, using an enzymatic method. The reliability of the measuring method was assessed by evaluating serum B2-M in 18 patients suffering from chronic renal failure (CRF). The severity and activity of IBD was estimated using the van Hees Activity Index and the True-love-Witts criteria for CD and UC patients respectively. Endoscopic evaluation for UC patients was done according to Baron's et al. classification; Riley's et al. criteria were used for histological evaluation. RESULTS: B2-M serum levels were significantly increased in all CD patients except those in remission. After 6 months treatment a second blood sample taken from CD patients with initially elevated B2-M levels proved to be compatible with CD severity at that time. Such a positive correlation was not assessed in UC patients; therefore, a second blood sample was considered unnecessary. Furthermore, CD patients with pancolitis, ileal-caecal, or small intestinal disease had higher B2-M levels than those with left-sided, anal, or perianal disease. CONCLUSIONS: B2-M serum levels could prove to be a useful marker in assessing not only the activity, severity, and extent of CD but the treatment efficacy as well.